Vertex Pharmaceuticals (VRTX) News Today $500.19 -0.96 (-0.19%) Closing price 05/5/2025 04:00 PM EasternExtended Trading$474.50 -25.69 (-5.14%) As of 07:47 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period BW Gestao de Investimentos Ltda. Takes $3.81 Million Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)BW Gestao de Investimentos Ltda. purchased a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 9,472 sharesMay 6 at 7:30 AM | marketbeat.comVertex pharmaceuticals projects 8% revenue growth in 2025 amid pipeline advancements and new launchesMay 6 at 7:00 AM | seekingalpha.comBaldwin Investment Management LLC Grows Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Baldwin Investment Management LLC increased its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 5.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,559 shares of the pharMay 6 at 6:57 AM | marketbeat.comBellevue Group AG Reduces Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Bellevue Group AG trimmed its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 14.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 487,434 shares of the pharmaceutical company's stocMay 6 at 6:32 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by BNP ParibasBNP Paribas grew its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 9.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,184 shares of the pharmaceutical company's stock after aMay 6 at 5:49 AM | marketbeat.comAmeriprise Financial Inc. Has $811.64 Million Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Ameriprise Financial Inc. increased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 7.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,015,523 shares of the pharmaceutMay 6 at 5:48 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stake Raised by Alyeska Investment Group L.P.Alyeska Investment Group L.P. increased its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 2,212.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 77,535 shares of thMay 6 at 5:31 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Aptus Capital Advisors LLCAptus Capital Advisors LLC grew its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 18.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 22,168 shares of the pharmaceutical company's stockMay 6 at 5:22 AM | marketbeat.comAxa S.A. Sells 3,620 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Axa S.A. lowered its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 2.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 140,790 shares of the pharmaceutical company's stock after selling 3,62May 6 at 5:14 AM | marketbeat.comSchonfeld Strategic Advisors LLC Reduces Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Schonfeld Strategic Advisors LLC lessened its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 89.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 7,400 shares of the pharmaceutical company's stock after selliMay 6 at 4:49 AM | marketbeat.comVertex Pharmaceuticals Inc (VRTX) Q1 2025 Earnings Call Highlights: Revenue Growth Amid ChallengesMay 6 at 2:15 AM | gurufocus.comVertex Pharmaceuticals Incorporated (VRTX) Q1 2025 Earnings Call TranscriptMay 5 at 8:31 PM | seekingalpha.comVertex Pharmaceuticals Stock Falls On Q1 Earnings, Revenue Miss — Company Raises Low End Of FY25 Revenue GuidanceMay 5 at 5:36 PM | benzinga.comVertex Pharmaceuticals (VRTX) Reports Lower Q1 Earnings, Misses Revenue EstimatesMay 5 at 5:03 PM | gurufocus.comVertex misses quarterly results on weaker-than-expected demand for cystic fibrosis drugMay 5 at 4:18 PM | reuters.comVertex Pharmaceuticals (VRTX) Sees Elevated Options Activity Ahead of Earnings | VRTX Stock NewsMay 5 at 4:07 PM | gurufocus.comVertex Has Lost Some Sizzle Into Q1 Earnings - Can Alyftrek, Journavx Reignite The Momentum?May 5 at 3:40 PM | benzinga.comVertex Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings CallMay 5 at 10:16 AM | benzinga.comAristotle Atlantic Partners LLC Decreases Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Aristotle Atlantic Partners LLC decreased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 5.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor oMay 5 at 7:02 AM | marketbeat.comStock Market Selloff: 4 No-Brainer Stocks to Buy Right NowMay 5 at 7:00 AM | fool.com3 No-Brainer Stocks to Buy in MayMay 5 at 6:45 AM | fool.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Atalanta Sosnoff Capital LLCAtalanta Sosnoff Capital LLC decreased its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 62.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 45,202 shares of the pharmaceutical company's stock aftMay 5 at 6:29 AM | marketbeat.comVertex Pharmaceuticals (VRTX) Earnings Preview: What to ExpectMay 4 at 6:14 PM | gurufocus.com1248 Management LLC Makes New $832,000 Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)1248 Management LLC bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 2,065 shares of the pharmaceutical company's stock, valued at aMay 4 at 7:45 AM | marketbeat.comMeiji Yasuda Life Insurance Co Reduces Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Meiji Yasuda Life Insurance Co cut its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 8.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 25,377 shares of the pMay 4 at 6:43 AM | marketbeat.comCaisse DE Depot ET Placement DU Quebec Has $57.07 Million Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Caisse DE Depot ET Placement DU Quebec cut its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 61.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 141,717 sharMay 4 at 5:37 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Comerica BankComerica Bank trimmed its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 7.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 49,578 shares of the pharmaceutical company's stock afMay 4 at 5:28 AM | marketbeat.com5 Growth Stocks to Buy in May and Go AwayMay 4 at 4:42 AM | fool.comWestbourne Investments Inc. Invests $1.33 Million in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Westbourne Investments Inc. purchased a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 3,306 shares of the pharmaceutical company's stock, valued at approximately $1,331May 3 at 7:08 AM | marketbeat.com4,100 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Purchased by Susquehanna Fundamental Investments LLCSusquehanna Fundamental Investments LLC bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 4,100 shares of the phaMay 3 at 5:08 AM | marketbeat.comTrade, Canadian Jobs in Spotlight Next WeekMay 2, 2025 | baystreet.caHow To Trade VRTX Stock Ahead of Its Q1?May 2, 2025 | forbes.comVoleon Capital Management LP Purchases Shares of 13,228 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Voleon Capital Management LP purchased a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 13,228 shares of the pharmaceutical company's stock, valued at approxiMay 2, 2025 | marketbeat.comAQR Capital Management LLC Lowers Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)AQR Capital Management LLC decreased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 48.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 245,785 shares of tMay 2, 2025 | marketbeat.comPDT Partners LLC Acquires New Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)PDT Partners LLC acquired a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 9,803 shares of the pharmaceutical compaMay 1, 2025 | marketbeat.comNorthern Trust Corp Raises Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Northern Trust Corp increased its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 15.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,721,049 shares of the pharmaceutical company's stock afterMay 1, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Has $219.62 Million Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)The Manufacturers Life Insurance Company decreased its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 12.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 545,366 shares of theMay 1, 2025 | marketbeat.comBeacon Pointe Advisors LLC Sells 793 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Beacon Pointe Advisors LLC reduced its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 4.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 16,203 shares of the pharmaceuticalMay 1, 2025 | marketbeat.comCalifornia State Teachers Retirement System Sells 11,807 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)California State Teachers Retirement System lessened its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 2.9% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 400,670 shares of the pharmaceutical coApril 30, 2025 | marketbeat.comVirtus ETF Advisers LLC Decreases Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Virtus ETF Advisers LLC decreased its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 69.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 753 shares of the pharmaceutical compApril 30, 2025 | marketbeat.comVertex Pharmaceuticals (VRTX) to Release Earnings on MondayVertex Pharmaceuticals (NASDAQ:VRTX) will be releasing its Q1 2025 earnings after the market closes on Monday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-5-vertex-pharmaceuticals-incorporated-stock/)April 30, 2025 | marketbeat.comPublic Employees Retirement Association of Colorado Trims Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Public Employees Retirement Association of Colorado lessened its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 2.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 418,563 shares of thApril 29, 2025 | marketbeat.comProsperity Consulting Group LLC Sells 661 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Prosperity Consulting Group LLC reduced its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 18.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,919 shares of the pharmaceutical company's stock after seApril 29, 2025 | marketbeat.comJohnson Financial Group Inc. Sells 5,283 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Johnson Financial Group Inc. reduced its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 71.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,110 shareApril 29, 2025 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Kovitz Investment Group Partners LLCKovitz Investment Group Partners LLC lowered its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 53.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 16,890 shares of the pharmaceutical company's stock after selling 19,193April 29, 2025 | marketbeat.comHancock Whitney Corp Cuts Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Hancock Whitney Corp lessened its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 43.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,527 shares of the pharmaceutical company's stock after sApril 29, 2025 | marketbeat.comWhat is Zacks Research's Estimate for VRTX FY2027 Earnings?Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) - Investment analysts at Zacks Research increased their FY2027 EPS estimates for shares of Vertex Pharmaceuticals in a research note issued on Wednesday, April 23rd. Zacks Research analyst R. Department now anticipates that the pharmApril 29, 2025 | marketbeat.comWhat is Zacks Research's Forecast for VRTX FY2027 Earnings?April 29, 2025 | americanbankingnews.comMy 5 Top Stocks to Buy Right Now in This Highly Volatile MarketApril 28, 2025 | fool.comZacks Research Analysts Boost Earnings Estimates for VRTXVertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) - Equities research analysts at Zacks Research raised their Q1 2027 earnings estimates for shares of Vertex Pharmaceuticals in a research note issued on Wednesday, April 23rd. Zacks Research analyst R. Department now forecasts that tApril 27, 2025 | marketbeat.com Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address VRTX Media Mentions By Week VRTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRTX News Sentiment▼0.980.72▲Average Medical News Sentiment VRTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRTX Articles This Week▼4126▲VRTX Articles Average Week Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Regeneron Pharmaceuticals News Alnylam Pharmaceuticals News Biogen News United Therapeutics News Incyte News BioMarin Pharmaceutical News Exelixis News Neurocrine Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VRTX) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Vertex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VRTX Stock Free VRTX Stock Alerts